Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$407M |
| 2 |
ExxonMobil
XOM
|
+$212M |
| 3 |
Microsoft
MSFT
|
+$200M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$183M |
| 5 |
Johnson & Johnson
JNJ
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$58.6M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$43M |
| 3 |
BCE
BCE
|
+$39M |
| 4 |
PETM
PETSMART INC
PETM
|
+$11.8M |
| 5 |
CFN
CAREFUSION CORPORATION
CFN
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.69% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 10.89% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Consumer Staples | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Ross Stores
ROST
$81.7B
| $39.9M | 0.11% |
758,192
+233,800
| +45% | +$11.6M |
|
227
Aon
AON
$75.7B
| $39.7M | 0.11% |
412,671
+156,100
| +61% | +$15.1M |
|
228
Sempra
SRE
$55.1B
| $38.9M | 0.1% |
712,800
+279,800
| +65% | +$15.4M |
|
229
Aptiv
APTV
$10.3B
| $38.8M | 0.1% |
486,200
+192,100
| +65% | +$14.4M |
|
230
Las Vegas Sands
LVS
$29.4B
| $37.6M | 0.1% |
683,139
+284,100
| +71% | +$15.8M |
|
|
VIAB
231
DELISTED
Viacom Inc. Class B
VIAB
| $37.4M | 0.1% |
547,770
+201,800
| +58% | +$13.9M |
|
|
BRCM
232
DELISTED
BROADCOM CORP CL-A
BRCM
| $37.2M | 0.1% |
859,989
+356,900
| +71% | +$15.6M |
|
233
CGI
GIB
$15.6B
| $37.1M | 0.1% |
878,800
+169,000
| +24% | +$6.92M |
|
|
PXD
234
DELISTED
Pioneer Natural Resource Co.
PXD
| $37.1M | 0.1% |
226,852
+94,200
| +71% | +$14.5M |
|
|
Y
235
DELISTED
Alleghany Corp
Y
| $36.8M | 0.1% |
75,600
+3,400
| +5% | +$1.59M |
|
236
Cummins
CMI
$87.4B
| $36.7M | 0.1% |
264,419
+102,000
| +63% | +$14.4M |
|
237
Verisk Analytics
VRSK
$23.6B
| $36.6M | 0.1% |
512,343
+55,000
| +12% | +$3.71M |
|
238
Roper Technologies
ROP
$39.9B
| $36.4M | 0.1% |
211,358
+94,600
| +81% | +$15.3M |
|
239
Netflix
NFLX
$318B
| $36.3M | 0.1% |
6,102,250
+2,401,000
| +65% | +$14.6M |
|
240
Boston Scientific
BSX
$73.1B
| $35.9M | 0.1% |
2,020,730
+788,200
| +64% | +$12.5M |
|
|
LO
241
DELISTED
LORILLARD INC COM STK
LO
| $35.8M | 0.1% |
548,465
+213,700
| +64% | +$14.2M |
|
242
Devon Energy
DVN
$49.9B
| $35.7M | 0.1% |
592,126
+232,000
| +64% | +$14.1M |
|
243
Bath & Body Works
BBWI
$3.89B
| $35.7M | 0.1% |
468,315
+182,953
| +64% | +$13.2M |
|
|
VRN
244
DELISTED
Veren
VRN
| $35.6M | 0.1% |
1,651,904
+287,993
| +21% | +$6.57M |
|
|
CMCSK
245
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $35.6M | 0.1% |
634,416
+235,500
| +59% | +$13.2M |
|
246
Ovintiv
OVV
$17.6B
| $35.5M | 0.09% |
638,560
+177,700
| +39% | +$11.2M |
|
247
Zoetis
ZTS
$30.9B
| $35.4M | 0.09% |
763,680
+297,700
| +64% | +$13.4M |
|
|
CTRA
248
DELISTED
Coterra Energy
CTRA
| $35M | 0.09% |
1,184,716
+181,600
| +18% | +$5.15M |
|
249
HCA Healthcare
HCA
$89.6B
| $34.8M | 0.09% |
462,322
+181,000
| +64% | +$13M |
|
250
EQT Corp
EQT
$33.8B
| $34.7M | 0.09% |
769,953
+130,060
| +20% | +$5.51M |
|
Similar funds
Swiss National Bank's Q1 2015 Portfolio in Review
As of Q1 2015, Swiss National Bank held 2,582 positions worth $37.5B, up 40% from $26.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Swiss National Bank deployed $10.3B of net new capital in Q1 2015, opening 14 new positions and adding to 1,633 existing holdings. Its largest new stake was Infosys: 2,143,352 shares worth $18.8M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was BCE, an estimated $39M trimmed.
- Swiss National Bank's largest Q1 2015 buy was Infosys: 2,143,352 shares worth $18.8M.
- Swiss National Bank added most to Apple in Q1 2015, an estimated $407M increase.
- Swiss National Bank's biggest Q1 2015 reduction was BCE, cutting an estimated $39M.
- Swiss National Bank fully exited Allergan Inc in Q1 2015, selling an estimated $58.6M.
- Swiss National Bank's ten largest holdings make up 14% of its $37.5B portfolio in Q1 2015.
- Swiss National Bank opened 14 new positions and closed 36 in Q1 2015.
- Swiss National Bank's portfolio value rose 40% quarter-over-quarter to $37.5B.
Based on Swiss National Bank's 13F filing for Q1 2015, filed 6 May 2015.